PhD Student in cancer invasion research - CT0321
The Cytoskeleton and Cancer Progression (CCP) group belongs to the Department
of Oncology, whose activities focus on the cellular and molecular mechanisms of
tumor progression using a wide range of cutting edge technologies, including
genomic, transcriptomic and proteomic analyses, and in vitro and in vivo
imaging modalities as well as state of-the art animal models for cancer
research. The CCP group focuses on actin regulatory proteins and related
signaling pathways driving tumor cell invasion and immune evasion, with the
goal to identify new prognostic markers and therapeutic targets (see our
webiste). We combine biochemistry, cell biology, reversegenetics and advanced
live-cell imaging approaches as well as mouse models of breast cancer
metastasis.